{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T12:51:48Z","timestamp":1782910308766,"version":"3.54.5"},"reference-count":25,"publisher":"Korean Cancer Association","content-domain":{"domain":["e-crt.org"],"crossmark-restriction":true},"short-container-title":["Cancer Res Treat"],"DOI":"10.4143\/crt.2025.815","type":"journal-article","created":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T08:24:04Z","timestamp":1764750244000},"update-policy":"https:\/\/doi.org\/10.4143\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A Phase II Study of Bendamustine Plus Rituximab in Patients with Relapsed or Progressive Marginal Zone Lymphoma: KCSG LY14-09"],"prefix":"10.4143","author":[{"given":"Jeong-Ok","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinny","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hye Jin","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shin Young","family":"Hyun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gyeong-Won","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ho-Young","family":"Yhim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyo Jung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong Seok","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dae Seog","family":"Heo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tae Min","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2954","published-online":{"date-parts":[[2025,12,3]]},"reference":[{"key":"ref1","first-page":"173","volume":"12","author":"Jung","year":"2019","journal-title":"Classification of malignant lymphoma subtypes in Korean patients: a report of the 4th nationwide study"},{"key":"ref2","first-page":"565","volume":"31","author":"Zucca","year":"2013","journal-title":"Addition of rituximab to chlorambucil produces superior event-free survival in the treatment of patients with extranodal marginal-zone B-cell lymphoma: 5-year analysis of the IELSG-19 Randomized Study"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2016.70.6994"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(12)61763-2"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-11-531327"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-011-1337-6"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2005.08.100"},{"key":"ref8","first-page":"4473","volume":"26","author":"Robinson","year":"2008","journal-title":"Phase II multicenter study of bendamustine plus rituximab in patients with relapsed indolent B-cell and mantle cell non-Hodgkin\u2019s lymphoma"},{"key":"ref9","first-page":"57","volume":"17","author":"Rummel","year":"2016","journal-title":"Bendamustine plus rituximab versus fludarabine plus rituximab for patients with relapsed indolent and mantle-cell lymphomas: a multicentre, randomised, open-label, non-inferiority phase 3 trial"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2006.09.2403"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1002\/sim.3123"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.ccr-21-1704"},{"key":"ref13","first-page":"1609","volume":"39","author":"Fowler","year":"2021","journal-title":"Umbralisib, a dual PI3Kdelta\/CK1epsilon inhibitor in patients with relapsed or refractory indolent lymphoma"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1200\/jco.19.00010"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-10-747345"},{"key":"ref16","first-page":"3898","volume":"35","author":"Dreyling","year":"2017","journal-title":"Phosphatidylinositol 3-kinase inhibition by copanlisib in relapsed or refractory indolent lymphoma"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/s2352-3026(14)00021-0"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/s1470-2045(05)70255-2"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1097\/jto.0b013e31822722b6"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6605348"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-015-2727-6"},{"key":"ref22","first-page":"2054","volume":"101","author":"Ogura","year":"2010","journal-title":"Phase I and pharmacokinetic study of bendamustine hydrochloride in relapsed or refractory indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-010-1254-8"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1097\/cm9.0000000000001463"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1007\/s12185-015-1767-3"}],"container-title":["Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/e-crt.org\/upload\/pdf\/crt-2025-815.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T12:26:50Z","timestamp":1782908810000},"score":1,"resource":{"primary":{"URL":"http:\/\/e-crt.org\/journal\/view.php?doi=10.4143\/crt.2025.815"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,3]]},"references-count":25,"URL":"https:\/\/doi.org\/10.4143\/crt.2025.815","relation":{},"ISSN":["1598-2998","2005-9256"],"issn-type":[{"value":"1598-2998","type":"print"},{"value":"2005-9256","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,3]]},"assertion":[{"value":"2025-08-01","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-12-02","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-12-03","order":2,"name":"published","label":"Published online","group":{"name":"publication_history","label":"Publication History"}}]}}